Advanced search×

Successful management of anti-Jra alloimmunization in pregnancy: a case report.

Akio Masumoto, Hisashi Masuyama, Yumi Sumida, Tomonori Segawa, and Yuji Hiramatsu

Gynecol Obstet Invest 69(2):81-3 (2010) PMID 19923849

Hemolytic disease of the fetus/newborn due to Jr(a) immunization is very rare and considered to be mild, and only routine obstetrical care is recommended for pregnant women sensitized to the Jr(a) antigen.

DOI: 10.1159/000259724
Version: za2963e q8za8 q8zbd q8zc8 q8zdd q8zec q8zf2 q8zg3
Buy PDF

Similar articles you may find interesting…

  1. The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder?
    Susan E Craword, Philip Fitchev, and Olga V Volpert

    Expert Opin Drug Discov (2013) PMID 23642051

    Pigment epithelium-derived factor (PEDF) was discovered as a neurotrophic factor secreted by retinal pigment epithelial cells. A decade later, it re-emerged as a powerful angiogenesis inhibitor guarding ocular function. Since then, significant advances were made identifying PEDF's mechanisms, target...
    Buy PDF
  2. Cyclin-dependent kinase inhibitor therapy for hematologic malignancies.
    Prithviraj Bose, Gary L Simmons, and Steven Grant

    Expert Opin Investig Drugs (2013) PMID 23647051

    Cyclin-dependent kinases (CDKs) regulate cell cycle progression. Certain CDKs (e.g., CDK7, CDK9) also control cellular transcription. Consequently, CDKs represent attractive targets for anticancer drug development, as their aberrant expression is common in diverse malignancies, and CDK inhibition ca...
    Buy PDF
  3. First case on successful management of manganism with renal transplantation.
    Pratish George, Suceena Alexander, and Chakko Korula Jacob

    Transplantation 95(9):e58-9 (2013) PMID 23648409

    Buy PDF